J&J | JNJ - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
AbbVie USD 7.61B 2.04B 2026-06
Abbott USD 2.39B 27M 2026-03
Amgen USD 2.08B 570M 2026-03
AstraZeneca USD 4.81B 894M 2026-06
Baxter International USD 362M 368M 2026-06
Bayer EUR 321M 2.67B 2026-06
Becton, Dickinson and Co. USD 39M 354M 2026-03
Biogen USD 647.3M 269.6M 2026-06
Boston Scientific USD 1.42B 261M 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
CONMED USD 18.36M 10.9M 2026-03
Cooper Companies USD -48.4M 240.6M 2026-03
Dexcom USD 269.5M 71.2M 2026-03
Edwards Lifesciences USD 529.3M 90.4M 2026-06
Eli Lilly USD 8.85B 583.8M 2026-03
Gilead Sciences USD -7.53B 10.11B 2026-06
GlaxoSmithKline GBP 2.68B 532M 2026-06
Globus Medical USD 157.07M 12.16M 2026-03
Insulet USD 118.7M 5.7M 2026-06
Integra LifeSciences USD -2.41M 6.72M 2026-03
Intuitive Surgical USD 940.4M 15.2M 2026-03
J&J USD 8.66B 839M 2026-06
Medtronic USD 2.26B 190M 2026-06
Merck USD -3.53B 6.95B 2026-03
Merit Medical Systems USD 53.55M 2.49M 2026-03
Novartis USD 4.27B 430M 2026-06
Pfizer USD -653M 5.84B 2026-06
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sanofi EUR 837M 1.17B 2026-06
Stryker USD 850M 855M 2026-03
Tandem Diabetes Care USD -19.88M 24.56M 2026-03
Teva Pharmaceutical Industries USD -455M 1.21B 2026-06
Vertex Pharmaceuticals USD 1.39B 138.9M 2026-06
Zimmer Biomet Holdings USD 487.5M 186.2M 2026-06
Zoetis USD 758M 3M 2026-03